,,iii  #aah? ,,congress  #b;d ,session  
,s4 ,,res4 #fcf  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,april #aj1 #bjbd,mr4 
,br[n 7= himself1 ,mr4 ,b>rasso1 ,mr4   
,wick]1 ,mr4 ,blum5?al1 ,mr4 ,casey1    
,mr4 ,book]1 ,mr4 ,:iteh\se1 ,ms4       
,klobu*>1 ,mr4 ,scott ( ,s\? ,c>ol9a1   
,mr4 ,m>%all1 ,mr4 ,braun1 & ,mr4 ,scott
 ( ,florida7 submitt$ ! foll[+          
resolution2 :i* 0 consid]$ & agre$ to   
,,resolution  ,designat+ ,febru>y #bi1  
#bjbd1 z ,r>e ,disease ,day4  ,:]eas a  
r>e disease or disord] is a disease or  
disord] t affects a small numb] (       
pati5ts2 ,:]eas1 9 ! ,unit$ ,/ates1 a   
r>e disease or disord] affects few] ?an 
#bjj1jjj individuals2 ,:]eas1 z ( ! date
 ( adoption ( ?is resolution1 m ?an     
#cj1jjj1jjj individuals 9 ! ,unit$      
,/ates are liv+ ) at lea/ #a ( ! m ?an  
#g1jjj kn[n r>e diseases or disord]s2   
,:]eas *ildr5 ) r>e diseases or disord]s
 acc\nt = a significant portion ( !     
population affect$ by r>e diseases or   
disord]s 9 ! ,unit$ ,/ates2 ,:]eas _m   

r>e diseases & disord]s are s]i\s &     
life-?reat5+2 ,:]eas #bjbd m>ks ! #da/  
anniv]s>y ( ! enactm5t ( ! ,orphan ,drug
 ,act 7,public ,law #ig-dad2 #if ,/at4  
#bjdi71 a l&m>k law enabl+ trem5d\s     
advances 9 ! rese>* & treatm5t ( r>e    
diseases & disord]s2 ,:]eas programs su*
 z ! ,accel]at+ ,r>e disease ,cures     
,program ( ! ,food & ,drug ,adm9i/ration
 7ref]r$ to 9 ?is preamble z ! ,,fda7   
aim to drive sci5tific & regulatory     
innovation & engagem5t to accel]ate !   
availability ( treatm5ts = pati5ts ) r>e
 diseases2 ,:]eas #bh ( ! #ee novel     
drugs approv$ by ! ,c5t] = ,drug        
,evaluation & ,rese>* ( ! ,,fda 9       
#bjbc-- 7#a7 7 approv$ to prev5t1       
diagnose1 or treat a r>e disease or     
condition2 &  7#b7 receiv$ an           
orphan-drug designation2 ,:]eas1 al?\gh 
! ,,fda has approv$ m ?an #a1ajj drugs &
 biological products = an orphan        
indication = ! treatm5t ( a r>e disease 
or disord]1 approximately #ij p]c5t (   
r>e diseases d n h a treatm5t approv$ by

 ! ,,fda = _! condition2 ,:]eas f9anc+  
life-alt]+ & lifesav+ treatm5ts c be    
*all5g+ = individuals ) a r>e disease or
 disord] & _! families2 ,:]eas          
individuals ) r>e diseases or disord]s c
 exp]i5ce difficulty 9 obta9+ accurate  
diagnoses & f9d+ physicians or treatm5t 
c5t]s ) exp]tise 9 _! r>e disease or    
disord]2 ,:]eas ! ,national ,in/itutes (
 ,heal? support innovative rese>* on !  
treatm5t ( r>e diseases & disord]s2     
,:]eas ,r>e ,disease ,day is obs]v$ ea* 
ye> on ! la/ day ( ,febru>y2 & ,:]eas   
,r>e ,disease ,day is a global ev5t t 0 
fir/ obs]v$ 9 ! ,unit$ ,/ates on        
,febru>y #bh1 #bjji1 & 0 obs]v$ 9 m ?an 
#ajf c\ntries 9 #bjbc3 ,n[1 !re=e1 be x 
,t ! ,s5ate-- 7#a7 designates ,febru>y  
#bi1 #bjbd1 z ,r>e ,disease ,day2 &     
7#b7 recognizes ! importance (1 )       
respect to r>e diseases & disord]s--    
7,a7 improv+ aw>5ess2  7,b7 enc\rag+    
accurate & e>ly diagnosis2 &  7,c7      
support+ national & global rese>* ef=ts 
to develop effective treatm5ts1         

diagno/ics1 & cures4